Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eli Lilly and Co (NYSE:LLY)

78.05
Delayed Data
As of May 26
 -0.29 / -0.37%
Today’s Change
64.18
Today|||52-Week Range
86.72
+6.12%
Year-to-Date
Pharma Stock Roundup: Label Expansion for Merck Drug, Aerie Up On Eye Data
May 26 / Zacks.com - Paid Partner Content
Nevada Senate Passes Bill to Force Diabetes Drug Manufacturers to Disclose Pricing Pr...
May 22 / TheStreet.com - Paid Partner Content
Radius Health Osteoporosis Drug Positive in Phase III Study
May 25 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: J&J's Pharma Pipeline Update, Shire's HAE Data & More
May 19 / Zacks.com - Paid Partner Content
Merck's (MRK) Keytruda Gets FDA Nod for Solid Tumor Cancers
May 24 / Zacks.com - Paid Partner Content
Endocyte (ECYT) Focused on Two Lead Pipeline Candidates
May 18 / Zacks.com - Paid Partner Content
AstraZeneca's Bydureon Fails to Reduce Cardiovascular Risk
May 24 / Zacks.com - Paid Partner Content
5 Reasons Why Merck (MRK) is a Good Stock to Buy Now
May 17 / Zacks.com - Paid Partner Content
The Good, the Bad and the Ugly (Boring Edition)
May 23 / TheStreet.com - Paid Partner Content
Teva (TEVA) Launches Glumetza Generic, Inks Deal with Otsuka
May 16 / Zacks.com - Paid Partner Content
Novartis' (NVS) Lung Cancer Drug Gets Positive CHMP Opinion
May 22 / Zacks.com - Paid Partner Content
Lilly's Migraine Drug Phase III Trials Meet Primary Endpoint
May 15 / Zacks.com - Paid Partner Content
Sanofi Wins Favorable CHMP Opinion for Biosimilar Humalog
May 22 / Zacks.com - Paid Partner Content